title: Large T Antigen-Specific Cytotoxic T Cells Protect Against Dendritic Cell Tumors through Perforin-Mediated Mechanisms Independent of CD4 T Cell Help.
abstract: Our newly generated murine tumor dendritic cell (MuTuDC) lines, generated from tumors developing in transgenic mice expressing the simian virus 40 large T antigen (SV40LgT) and GFP under the DC specific promoter CD11c, reproduce the phenotypic and functional properties of splenic wild type CD8α(+) conventional DCs. They have an immature phenotype with low co-stimulation molecule expression (CD40, CD70, CD80, and CD86) that is upregulated after activation with toll-like receptor ligands. We observed that after transfer into syngeneic C57BL/6 mice, MuTuDC lines were quickly rejected. Tumors grew efficiently in large T transgene-tolerant mice. To investigate the immune response toward the large T antigen that leads to rejection of the MuTuDC lines, they were genetically engineered by lentiviral transduction to express luciferase and tested for the induction of DC tumors after adoptive transfer in various gene deficient recipient mice. Here, we document that the MuTuDC line was rejected in C57BL/6 mice by a CD4 T cell help-independent, perforin-mediated CD8 T cell response to the SV40LgT without pre-activation or co-injection of adjuvants. Using depleting anti-CD8β antibodies, we were able to induce efficient tumor growth in C57BL/6 mice. These results are important for researchers who want to use the MuTuDC lines for in vivo studies.
authors.affiliation: Department of Biochemistry, Center of Immunity and Infection Lausanne, University of Lausanne , Lausanne , Switzerland.
authors.forename: Anaïs
authors.initials: A
authors.lastname: Duval
authors.affiliation: Department of Biochemistry, Center of Immunity and Infection Lausanne, University of Lausanne , Lausanne , Switzerland.
authors.forename: Silvia A
authors.initials: SA
authors.lastname: Fuertes Marraco
authors.affiliation: Department of Biochemistry, Center of Immunity and Infection Lausanne, University of Lausanne , Lausanne , Switzerland.
authors.forename: Dominik
authors.initials: D
authors.lastname: Schwitter
authors.affiliation: Department of Biochemistry, Center of Immunity and Infection Lausanne, University of Lausanne , Lausanne , Switzerland.
authors.forename: Line
authors.initials: L
authors.lastname: Leuenberger
authors.affiliation: Department of Biochemistry, Center of Immunity and Infection Lausanne, University of Lausanne , Lausanne , Switzerland.
authors.forename: Hans
authors.initials: H
authors.lastname: Acha-Orbea
keywords: CD4 T cells; CD8 T cell; dendritic cell; large T antigen; perforin; tolerance
references.citation: Mol Cancer. 2010 Nov 22;9:299
references.pmid: 21092230
references.citation: Innate Immun. 2011 Feb;17(3):338-52
references.pmid: 20501515
references.citation: Immunity. 2002 Aug;17(2):211-20
references.pmid: 12196292
references.citation: Blood. 2008 Feb 15;111(4):2073-82
references.pmid: 18029555
references.citation: Annu Rev Immunol. 2002;20:323-70
references.pmid: 11861606
references.citation: PLoS One. 2010 Jun 16;5(6):e11144
references.pmid: 20585396
references.citation: J Immunol. 2000 Dec 1;165(11):6047-55
references.pmid: 11086036
references.citation: Gene Ther. 2001 Dec;8(23):1813-4
references.pmid: 11803402
references.citation: Nature. 2005 Sep 1;437(7055):141-6
references.pmid: 16136144
references.citation: Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):351-8
references.pmid: 11773639
references.citation: Cancer Res. 2001 Jan 1;61(1):333-8
references.pmid: 11196183
references.citation: Science. 2000 Nov 17;290(5495):1354-8
references.pmid: 11082062
references.citation: Front Immunol. 2012 Nov 07;3:331
references.pmid: 23162549
references.citation: J Exp Med. 1996 Oct 1;184(4):1543-7
references.pmid: 8879227
references.citation: J Virol. 2000 Aug;74(15):6922-34
references.pmid: 10888631
references.citation: Curr Protoc Hum Genet. 2007 Jul;Chapter 12:Unit 12.10
references.pmid: 18428406
references.citation: Cancer Res. 1979 Nov;39(11):4724-31
references.pmid: 498099
references.citation: PLoS One. 2011 Mar 31;6(3):e17657
references.pmid: 21483862
references.citation: Nat Immunol. 2005 Mar;6(3):280-6
references.pmid: 15685176
references.citation: Mol Biol Med. 1990 Feb;7(1):83-96
references.pmid: 2157938
references.citation: J Exp Med. 2002 Dec 16;196(12):1627-38
references.pmid: 12486105
references.citation: J Virol. 1999 Mar;73(3):2527-36
references.pmid: 9971838